CellBion Co., Ltd. (KOSDAQ:308430)
12,250
-960 (-7.27%)
At close: Jul 20, 2026
-50.30% (1Y)
| Market Cap | 170.48B -46.0% |
| Revenue (ttm) | 2.08B -19.1% |
| Net Income | -8.54B |
| EPS | -666.35 |
| Shares Out | 12.91M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,055 |
| Open | 13,500 |
| Previous Close | 13,210 |
| Day's Range | 12,160 - 13,710 |
| 52-Week Range | 12,250 - 42,200 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |